SIR 2025
General IR
Scientific Session
Stella Chen (she/her/hers)
Medical Student
Tufts University School of Medicine, United States
Ian W. Sullivan, DO
Interventional Radiologist
Tufts Medical Center, Department of Interventional Radiology, United States
Nathan E. Frenk, MD
Interventional Radiologist
Tufts Medical Center, Department of Interventional Radiology, United States
Kei Yamada, MD
Interventional Radiologist
Tufts Medical Center, Department of Interventional Radiology, United States
This study compares traditional minimally invasive treatment of necrotizing pancreatitis with a novel interventional approach, Drain Irrigation with Vacuum Assistance (DIVA) necrosectomy.
Materials and Methods:
A retrospective review of patients with necrotizing pancreatitis who received a minimally invasive necrosectomy at a tertiary care academic center was performed. These patients received video assisted retroperitoneal debridement (VARD) or endoscopic transgastric necrosectomy (ETN) (n=13) or DIVA (n=6). In the DIVA procedure, a suction device is inserted in a mature drain tract in tandem with an irrigation catheter and vacuum debridement is performed with negative pressure reaching 98.9kPa. Demographic data and pre-procedure severity were recorded. The number of procedures each patient received, time to resolution, and the number and nature of complications were compared between the VARD/ETN and DIVA groups.
Results:
Patients who received DIVA had higher disease severity at presentation (Acute Physiology and Chronic Health Evaluation (APACHE) II score: VARD/ETN vs DIVA, 5.69 vs 15.0, p = 0.014), but reached resolution of abdominal fluid collections more quickly (VARD/ETN vs DIVA, 144.92 vs 84.67 days, p = 0.035). While 1 of 13 (7.7%) of VARD/ETN patients died, all DIVA patients reached resolution with no mortality. DIVA is qualitatively associated with fewer complications, though this difference is not statistically significant (VARD/ETN vs DIVA, 54.8% vs 33.3%, RR 0.62, p = 0.45).
Conclusion:
Patients receiving IR-guided DIVA necrosectomy experienced a faster time to resolution despite an initially more severe presentation, compared to VARD/ETN patients. These preliminary results warrant further research into DIVA’s role in treatment of necrotizing pancreatitis.